Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Tempus AI (TEM) Stock Is Rising Wednesday: What's Going On?

Shares of Tempus AI Inc (NASDAQ:TEM) are trading higher Wednesday, potentially building on momentum from last week given the lack of company-specific news. Here’s what investors need to know.

Benzinga

EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions

Scienture Holdings, Inc. (NASDAQ:SCNX) announced on Wednesday the formalization of multiple commercial group purchasing organization (GPO) agreements for its new drug, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.

Benzinga

Walmart sets a timeline for removing synthetic dyes and other additives from its food brands

Walmart says it plans to remove synthetic dyes and 30 other food additives from its store brands sold in the United States by January 2027

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Federal agencies blame Democrats for looming shutdown in apparent Hatch Act violation

Housing and VA departments attack ‘radical left’ despite law limiting political activities of government employees

The Guardian - US

Can Americans Trust RFK Jr.'s Health Advice? A Breakdown on Vaccines, Autism, Food Dyes, and More

As ever, be cautious about what you hear from the Department of Health and Human Services.

Reason

Woman’s ‘Kybella’ Face Transformation Stuns People After Her Extreme Recovery Phase Goes Viral

Bored Panda contacted four dermatologists and plastic surgeons to find out more about Kybella, the FDA-approved treatment that targets the stubborn "double chin."

Bored Panda

Here are some effects of a government shutdown if Congress, Trump don't reach a deal

The U.S. government is nearing a partial shutdown, with a range of effects on public services and the broader economy

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

2 Penny Stocks That Wall Street Believes Can Soar Over 200%

Penny stocks are highly volatile, but some of them have the potential to deliver outsized returns.

Barchart

RFK Jr. orders abortion pill ‘safety review’ based on junk science – just like his Tylenol autism claims

Guess which conservative think tank supplied the "evidence" for this one...

We Got This Covered

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

Benzinga

The abortion pill is safe. But why should Trump let facts get in the way?

RFK Jr is conducting a review of mifepristone, citing a deeply flawed study. The move could be devastating for women

The Guardian - US

Pfizer sued in US over contraceptive that women say caused brain tumours

US class action lawsuit alleges company failed to warn about risks of using contraceptive injection Depo-Provera

The Guardian - UK

3 Healthcare Stocks Using AI to Drive Growth

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

MarketBeat

9 Warning Signs a Restaurant Won’t Last Due to Bad Service

A great menu can’t save a place that treats guests poorly. Service sets the tone, protects margins, and builds repeat visits. When it’s bad, costs rise, reviews crash, and regulars vanish. You notice it fast: long waits, missing items, mixed-up bills. If you care about your time and money, spotting…

Grocery Coupon Guide

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

‘Anti-expert crusade’: what Trump’s hollowing out of US health institutions means for Australia

The impact of Robert F Kennedy Jr on US health organisations will affect research funding and access to medicines but may force Australia to step up, say experts

The Independent UK

What is cesium 137? FDA detects radioactive contamination in second product

Federal regulators have detected possible radioactive contamination in spices exported from Indonesia

The Guardian - US

What is leucovorin, the drug the FDA approved to treat autism?

This week the FDA approved the generic drug as a treatment for autism – a move that shocked health experts

Benzinga

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that could determine whether affected women can pursue their cases in court.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

Benzinga

FDA Approves Crinetics Pharma's First Daily Pill For Rare Growth Disorder

On Thursday, the U.S. Food and Drug Administration (FDA) approved Crinetics Pharmaceuticals, Inc.’s (NASDAQ: CRNX) Palsonify (paltusotine) for the first-line treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option.

Benzinga

Why Is Organogenesis Stock Trading Lower Friday?

Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for the management of symptoms associated with knee osteoarthritis (OA).

Benzinga

FDA Expands Use Of Regeneron's Evkeeza To Infants With Rare Cholesterol Disorder

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals, Inc.’s (NASDAQ: REGN) Evkeeza (evinacumab-dgnb) ANGPTL3 antibody as an adjunct to diet and exercise and other lipid-lowering therapies for the treatment of children from age 1 to less than 5 years old with homozygous familial hypercholesterolemia (HoFH).

Benzinga

Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday.

Benzinga

FDA Approves Eli Lilly's Drug For Advanced Breast Cancer

On Thursday, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Co.’s (NYSE: LLY) Inluriyo (imlunestrant) for adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2–), ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed after at least one line of endocrine therapy (ET).

Benzinga

Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?

Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company developing non-opioid, non-IV sedation therapies for hospitals and outpatient care.

1 … 36 37 38 39

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.